Overview

Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

Status:
Completed
Trial end date:
2021-04-16
Target enrollment:
Participant gender:
Summary
To investigate the comparative bioavailability of edaravone oral suspension administered orally and via a nasogastric tube in healthy adult subjects
Phase:
Phase 1
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation
Treatments:
Edaravone